A caller with a knee that has hurt for eight months reaches your regenerative orthopedics practice. Maybe a surgeon already told him he needs an operation, maybe he has only been reading. Either way, his first real question is not about your outcomes or your evidence. It is four words: does insurance cover this? How your front desk answers that question in the next fifteen seconds decides whether he books a consultation or thanks you and hangs up.

This is the coverage caller, and he is more common in regenerative medicine than in almost any other premium vertical, because the treatments sit in a gap: clinically serious, often expensive, and mostly paid out of pocket. The instinct at the desk is to answer honestly and fast, which usually means a flat no. That flat no is where the booking dies.

What the coverage answer actually is

The honest answer, for most orthopedic uses, is that these treatments are not covered, and it helps to know exactly how firm that is before the phone rings.

• Commercial insurers. Aetna, Cigna, UnitedHealthcare, and Blue Cross Blue Shield generally classify platelet-rich plasma for orthopedic indications as investigational or experimental, and industry coverage guides estimate that roughly 85 to 95 percent of orthopedic PRP claims are denied.

• Medicare. Medicare does not cover PRP for knee osteoarthritis or most orthopedic uses. The narrow exception under National Coverage Determination 270.3 applies to chronic non-healing diabetic, pressure, or venous wounds, and only inside approved research studies.

• The one outlier. Tricare is the provider most often cited as offering any limited PRP coverage. For nearly everyone else, this is a cash-pay conversation.

So the caller who leads with coverage is, in most cases, going to hear that his plan will not pay. That fact is not the problem. The problem is treating it as the end of the conversation instead of the start of one.

Why a flat no loses a high-intent caller

The coverage question is rarely only about coverage. A person who has lived with joint pain for months and is calling a regenerative practice by name is not shopping for the cheapest option. He is trying to answer a harder question underneath the billing one: is this real, and is it worth paying for myself. When the desk answers the surface question with a single word and moves on, it never reaches the real one.

The other failure is the quote war, where the desk answers a coverage question with a raw price and nothing else. A number with no context sounds like a cost, not a value, and the caller does what anyone does with an unexplained price: he calls the next clinic. The distinction between callers who confuse the treatments, and how the desk should separate them, is the same intake discipline covered in how the front desk handles PRP-versus-stem-cell confusion, and the credibility case that makes cash-pay defensible is laid out in the evidence a regenerative practice should have ready on the first call.

What a well-built intake does with the coverage question

A front desk built for this vertical does four things with the coverage question, none of which require pretending the treatment is covered.

• Answer plainly, then reframe. Confirm that most plans treat it as out of pocket, then move immediately to what the caller actually gets and what a course typically involves, rather than leaving him alone with a no.

• Give the real range, with context. A single knee PRP session commonly runs about 500 to 1,500 dollars, higher in major metros, and most patients are quoted a series of two to three sessions, putting a full course roughly in the 1,000 to 4,500 dollar range. Framed as a defined course, that reads very differently than a bare number.

• Name the payment paths. PRP qualifies as a medical expense under IRS Publication 502, so HSA and FSA dollars can apply. That single fact changes the effective cost and signals that the practice has done this before.

• Route to a person, not a dead end. The desk cannot decide candidacy, so the job is to book the consultation and hand off cleanly. The cost of not routing that caller is the theme of why regenerative practices cannot afford to lose the high-value lead.

The math most practices have not run

Illustrative model - not a client result or guarantee. Suppose a regenerative practice fields 150 inbound inquiries in a month and a third of them open with the coverage question. If half of those coverage callers are lost to a flat no, that is 25 high-intent people a month who wanted a reason to stay and were not given one. At a course value in the low thousands, the monthly figure attached to one poorly handled sentence gets large quickly. The point is directional, not a forecast for your practice: the coverage question is not a cost objection to survive, it is the most winnable moment on the call, and it is being lost at the desk. This is Pillar One, the Zero-Miss Intake Protocol, applied to the exact sentence where regenerative callers leak, and the wider framing lives in the Four Revenue Recovery Pillars.

References

• Regenerative-medicine coverage guides (Orthopedic PRP, Resilience Orthopedics, Desert Spine and Sports), 2026: commercial-insurer investigational classifications and the estimated 85 to 95 percent orthopedic PRP denial rate.

• Medicare National Coverage Determination 270.3 (chronic wounds, research-study limited); Tricare limited-coverage exception.

• 2026 PRP cost surveys (Regenerative Joint Clinics, BetterCare): 500 to 1,500 dollars per session, 1,000 to 4,500 dollars per course; IRS Publication 502 on HSA and FSA eligibility.

Next Step

If your premium practice runs more than 100 inbound consult inquiries a month and has no structured measurement of how many never reach a scheduled consultation, your pipeline is leaking revenue. We quantify this for your practice in a 30-minute Intake Leak Audit.

• Request an Intake Leak Audit: expand@thethinkingrobot.com

• Audit Real-Time Conversational Velocity: Talk to Rosey, our AI receptionist, at +1 (720) 776-1664.